Page 1

PATIENT INFORMATION

JANE DOE

Age: 21 years
Date of Birth: 11/07/86
Location/ID: PRIVATE OFFICE

PHYSICIAN

JOHN SMITH, M.D

1234 JOHN WAY
HERCULES, CA 94547

CC: JACK SMITH M.D.

SPECIMEN INFORMATION

Accession # WCC-08-99999

Collected:02/15/2008
Received:02/15/2008
First Screened:02/16/2008
Reported:02/22/2008

HISTORY

MATURATION INDEX

SPECIMEN SOURCE: CERVICAL/VAGINAL/1 THINPREP/1 ONESWAB Slide
LMP: NOT GIVEN

ESTROGEN EFFECT (HORMONAL PATTERN): COMPATIBLE WITH AGE AND/OR HISTORY.


PAP TEST RESULTS WITH IMAGERDate Reported: 2/22/2008

NEGATIVE for intraepithelial lesion or malignancy. Endocervical cells or associated benign metaplastic cells present. Trichomonads not present. Negative for trichomonads and candida. Actinomycosis not identified.
Management Recommendation: Cytology Negative, HPV Negative: Routine Screening at clinically appropriate interval, as suggested by the Consensus Workshop or at three years. (Obstetrics and Gynecology 2004;103:302-309)

Pathologist: JOHN COMPAGNO M.D.,MEDICAL DIRECTOR



HUMAN PAPILLOMA VIRUS TEST RESULTS BY PCRDate Reported: 2/20/2008

HPV IdentificationNegative
The sample is negative for the presence of HPV DNA. These results do not exclude the possibility of HPV not detected due to sampling or assay sensitivity. This specimen tested negative for: LVX160, CP8061, CP6108, 6, 11, 16, 18, 26, 30, 31, 32, 33, 34, 35, 39, 42, 43, 44, 45, 51, 52, 53, 54, 55, 56, 57, 58, 59, 61, 62, 64, 66, 67, 68, 69, 70, 72, 73, 74, 81, 82, 83, 84 and "Unknown." The presence of certain HPV types is an established risk factor for the development of cellular dysplasia or neoplasia. Identification of the specific HPV type permits the assignment of disease risk, and is important to the clinical management of the patient.

Pathologist: JOHN COMPAGNO, M.D., MEDICAL DIRECTOR

TREPONEM PALLIDUM (SYPHILIS) BY RT-PCRDate Reported: 2/22/2008

Treponem Pallidum: Positive   T. pallidum is the etiologic agent of venereal syphilis. PCR detects the 16S rRNA of T. pallidum and represents a sensitive method for the detection of the organism. Serious consideration should be given to verification with MHA-TP or similar serum studies.

Pathologist: JOHN COMPAGNO, M.D., MEDICAL DIRECTOR

This test was developed and its performance characteristics determined by Medical Diagnostic Laboratories, LLC, 2439 Kuser Road, Hamilton, NJ 08690. It has not been cleared or approved by the U.S. Food and Drug Administration. The FDA has determined that such clearance or approval is not necessary.

Note: For DNA Tests Supporting Documentation, see http://www.wcpl.com/dna_support_doc.asp

Note: The following tests are available for 60 days post collection if specimen submitted as a ThinPrep®. Please call (800) 794-9737 for additional testing, if desired.

712 Alfred Nobel Drive . Hercules, CA 94547 . toll free 800.794.9737 . fax 510.662.5240 . www.wcpl.com . John Compagno, M.D., Medical Director
PATHOLOGY/CYTOPATHOLOGY CONSULTATION REPORT